None
Conditions
Interventions
Sponsors
Wuhan Fourth Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Age 18 to under 75; 2. ASA classification I-III; 3. Planned for elective fiberoptic bronchoscopy; 4. Patient agrees to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Severe hearing impairment or abnormal development of the auricle or external ear canal; 2. Implanted cardiac pacemaker or defibrillator; 3. History of severe neurological or psychiatric illness; 4. Allergy to remimazolam or its ingredients; 5. Long-term use of sedative or hypnotic drugs; 6. Any case with documents signed refusing participation in medical research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome measure: The total dosage of remimazolam (in milligrams).; | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety indicators: Incidence and severity of hypotension and bradycardia.;Waking-up quality indicator: The time from the cessation of sedation to the restoration of consciousness.; | — |
Countries
China
Contacts
Public ContactCheng jiangxia
Wuhan Fourth Hospital
Outcome results
None listed